FDA Field Operations Would Endure Reductions Under Budget

President Obama’s FY 2016 blueprint includes cuts to ‘low-priority’ enforcement, surveillance and other activities in FDA human drugs and biologics programs, but still increases those operations overall.

Field operations in FDA’s human drugs program would bear the brunt of the reductions included in the agency’s fiscal year 2016 budget request.

The proposed cuts were described as part of an effort to focus on the most important compliance and other activities, even as FDA continues its work to improve oversight of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America